Literature DB >> 6402096

Antiemetic effect of nonabine in cancer chemotherapy: a double blind study comparing nonabine and chlorpromazine.

C B Archer, P L Amlot, J R Trounce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6402096      PMCID： PMC1546960          DOI： 10.1136/bmj.286.6362.350-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

Review 1.  Potential therapeutic agents derived from the cannabinoid nucleus.

Authors:  H G Pars; J F Howes
Journal:  Adv Drug Res       Date:  1977

2.  Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.

Authors:  S E Sallan; N E Zinberg; E Frei
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

3.  delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.

Authors:  V S Lucas; J Laszlo
Journal:  JAMA       Date:  1980-03-28       Impact factor: 56.272

Review 4.  The control of chemotherapy-induced emesis.

Authors:  L J Seigel; D L Longo
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391
  4 in total
  2 in total

Review 1.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

2.  Pilot investigation of the quantitative EEG and clinical effects of ketazolam and the novel antiemetic nonabine in normal subjects.

Authors:  G R McClelland; J A Sutton
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.